Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers

News Direct

Dec 06, 2022

–News Direct–

Contact Details

Proactive Investors USA

+1 347-449-0879

na-editorial@proactiveinvestors.com

View original content to download multimedia: https://newsdirect.com/news/context-therapeutics-announces-bispecific-antibody-clinical-candidate-to-treat-cldn6-cancers-478676962

TARA MANUFACTURING TO PRESENT LARGEST DONATION IN…

--News Direct--Contact DetailsProactive Investors USAProactive Investors USA+1 347-449-0879na-editorial@proactiveinvestors.comView original content to download multimedia: https://newsdirect.com/news/context-therapeutics-announces-bispecific-antibody-clinical-candidate-to-treat-cldn6-cancers-478676962

Joe Miller Joins Ballast Rock Private Wealth…

TRUST RELATIONS NAMED A FINALIST FOR WOMEN-RUN…